The Impact of FDA New Drug Approval on Abnormal Return of Nasdaq Biotech Stock
碩士 === 長庚大學 === 企業管理研究所 === 97 === We observe two kinds of stocks. One is the components of Nasdaq Biotechnology Index (hereafter, cNBI) and the other is components of Phlx Drug Index (hereafter, cRXS). This study use an event study methodology for calculating abnormal return (hereafter, AR) and cum...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Published: |
2009
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/64978819916415095797 |